VAI is one of the three classifications, the U.S. FDA issues implying objectionable conditions or practices were found, during the inspection, but the regulator is not prepared to take or recommend any administrative or regulatory action
U.S. FDA issues VAI classification to Natco Pharma’s FDF unit in Vizag
Published ·

Keep reading
Related stories








